Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Endocrinology and metabolism indexChapter sections
Purpose and principlesIndications, selection and cautionsMethod and interpretationClinical next stepsRisks, monitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook9 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Diagnosing diabetes and prediabetes

Endocrinology and metabolism · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Diagnose the emergency before refining diabetes type

Weight loss, vomiting, abdominal pain, deep breathing, dehydration, altered consciousness or acute illness with hyperglycaemia requires immediate glucose, blood ketones and acid-base assessment. Children, pregnant people and anyone with suspected type 1 diabetes can deteriorate rapidly, and an HbA1c request is not an acute safety strategy.

Action: Use ABCDE, capillary glucose and ketones, obtain a venous blood gas and electrolytes, and start the local DKA, HHS or hypoglycaemia pathway when criteria are met. Begin appropriate insulin promptly when type 1 diabetes is clinically likely; do not await autoantibodies, C-peptide or routine outpatient confirmation.

Purpose and principles

Apply diagnostic glucose and HbA1c criteria correctly, confirm asymptomatic results, recognise when HbA1c is unreliable, and classify urgent presentations safely.

Diabetes is diagnosed by sustained glycaemia above thresholds associated with complications, but the correct test depends on clinical context. In a person with osmotic symptoms such as polyuria, polydipsia or unexplained weight loss, a single diagnostic-range venous plasma glucose is sufficient; if symptoms are absent, repeat the same test or use another diagnostic test to confirm. Fasting means no caloric intake for the required interval, and the two-hour value belongs to a standard 75 g oral glucose tolerance test. HbA1c is convenient because fasting is unnecessary and it captures longer exposure, yet it cannot show acute metabolic decompensation and becomes unreliable when haemoglobin structure, erythrocyte turnover or recent glucose change uncouples the value from current plasma glucose.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
Endocrinology and metabolismOriginal SBA

Confirming asymptomatic diabetes

A well adult with no osmotic symptoms has an HbA1c of 50 mmol/mol on routine risk assessment, with no recognised condition making HbA1c unreliable. What is the best next diagnostic step?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Endocrinology and metabolism topics →
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • Diabetes UK professional diagnostic criteriaVenous glucose, HbA1c, confirmation and invalidity criteria.
  • NICE NG17 type 1 diabetesUrgent diagnosis, autoantibodies and classification of adult type 1 diabetes.
  • NICE PH38 diabetes preventionRisk identification, intensive lifestyle programmes and reassessment for high-risk adults.
  • JBDS diabetic ketoacidosis guidanceMetabolic emergency assessment at diagnosis.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Diagnosis must be followed immediately by risk and type assessment. Someone with ketones, catabolic symptoms or possible type 1 diabetes needs same-day specialist treatment even if phenotype seems compatible with type 2. Conversely, a well asymptomatic person with one borderline HbA1c benefits from confirmation, cardiovascular risk review and prevention rather than premature disease labelling. Non-diabetic hyperglycaemia includes HbA1c 42–47 mmol/mol or a fasting glucose below the diabetic threshold but above the normal range in the applicable guidance. Explain that risk is modifiable, offer an evidence-based intensive lifestyle programme when eligible, and reassess at least annually or sooner if symptoms develop. Ethnicity, deprivation, mental illness, steroid exposure, polycystic ovary syndrome and previous gestational diabetes may alter risk and case-finding, but never replace biochemical criteria.

Key points

  • Classic symptoms plus a diagnostic-range venous plasma glucose can establish diabetes; an asymptomatic abnormal result normally needs confirmation on another day.
  • Diagnostic thresholds are fasting venous plasma glucose at least 7.0 mmol/L, random or two-hour OGTT glucose at least 11.1 mmol/L, or HbA1c at least 48 mmol/mol when valid.
  • HbA1c 42–47 mmol/mol indicates non-diabetic hyperglycaemia and increased future risk, not established diabetes; offer prevention support and planned reassessment.
  • Do not use HbA1c to exclude rapidly evolving type 1 diabetes, short-duration symptoms, acute pancreatic injury, pregnancy-related diabetes or other settings where red-cell biology distorts it.
  • A laboratory venous plasma glucose is the diagnostic standard; capillary meters are invaluable for immediate triage but should not silently replace confirmation in a stable person.
  • After diagnosing diabetes, classify its likely type using age, tempo, phenotype, ketones, family history, medicines, pancreatic disease and autoimmune evidence rather than body size alone.
  • A normal HbA1c can coexist with clinically important recent hyperglycaemia because it averages prior exposure and is weighted by erythrocyte lifespan.
  • Pregnancy has separate screening and diagnostic pathways; do not apply non-pregnant HbA1c criteria to suspected gestational diabetes.

Indications, selection and cautions

Symptomatic hyperglycaemia

Polyuria, nocturia, thirst, blurred vision, recurrent candidiasis, fatigue and unintentional weight loss increase pre-test probability and allow one diagnostic-range venous glucose to establish diabetes.

Catabolic or ketotic presentation

Rapid weight loss, vomiting, abdominal pain, tachypnoea, dehydration or raised blood ketones suggests insulin deficiency and requires urgent type 1 and DKA assessment regardless of age or body mass index.

HbA1c mismatch

Suspect invalidity when HbA1c conflicts with repeated glucose, symptoms began recently, anaemia or haemolysis is present, haemoglobinopathy or transfusion is relevant, or renal disease alters red-cell survival.

Non-diabetic hyperglycaemia

HbA1c 42–47 mmol/mol identifies increased diabetes and cardiovascular risk but is not a diagnosis of diabetes; communicate both the opportunity for prevention and the need for surveillance.

Atypical diabetes type

Very young onset, a strong multigenerational pattern, pancreatic disease, hearing loss, renal anomalies, autoimmune comorbidity or unexpected treatment response should broaden classification beyond types 1 and 2.

Method and interpretation

  1. 01
    Venous fasting plasma glucoseFirst step
    Why
    Diagnose dysglycaemia with a standardised measurement after the required fasting interval.
    Interpretation and limitations
    At least 7.0 mmol/L is diagnostic in a symptomatic person and requires confirmation if asymptomatic. A lesser elevation may indicate non-diabetic hyperglycaemia and should be interpreted using current criteria.
  2. 02
    HbA1c
    Why
    Estimate chronic glycaemic exposure and diagnose diabetes when erythrocyte and clinical conditions make it valid.
    Interpretation and limitations
    At least 48 mmol/mol is diagnostic with confirmation when asymptomatic; 42–47 mmol/mol denotes high risk. A lower result does not exclude recent-onset type 1 diabetes.
  3. 03
    75 g oral glucose tolerance test
    Why
    Detect impaired glucose handling when fasting glucose or HbA1c does not adequately answer the question and in specified pathways.
    Interpretation and limitations
    A two-hour venous plasma glucose at least 11.1 mmol/L meets a diabetes criterion outside pregnancy. Intermediate values are classified by the applicable prevention guidance.
  4. 04
    Random venous plasma glucose
    Why
    Confirm clinically suspected diabetes without waiting for fasting when classic symptoms are present.
    Interpretation and limitations
    At least 11.1 mmol/L with classic symptoms supports diagnosis. Without symptoms, obtain a confirmatory diagnostic test rather than relying on an isolated value.
  5. 05
    Blood ketones and venous blood gas
    Why
    Detect insulin-deficient decompensation at presentation, including euglycaemic ketoacidosis.
    Interpretation and limitations
    Ketonaemia with metabolic acidosis activates the DKA pathway. Ketones without acidosis still require clinical assessment, sick-day action and close review.
  6. 06
    Diabetes-specific autoantibodies
    Why
    Support classification when type 1 diabetes is suspected, particularly near diagnosis when antibodies have greatest discriminative value.
    Interpretation and limitations
    One or more positive antibodies support autoimmune diabetes; negative tests do not automatically prove type 2, and C-peptide may later help if uncertainty persists.

Clinical next steps

01AcuteSeparate metabolic emergency from stable diagnosisFirst stepA person has hyperglycaemia with illness, weight loss, vomiting, ketotic symptoms or altered consciousness.+
  1. 1Check bedside glucose and blood ketones immediately, then obtain venous gas, electrolytes and hydration observations without waiting for HbA1c.
  2. 2Start the local DKA or HHS protocol when criteria are met and seek same-day diabetes or paediatric support for possible type 1 diabetes.
  3. 3Once safe, preserve diagnostic history and obtain classification tests that will change care, without interrupting essential insulin to improve test interpretation.
02ConfirmDiagnose stable dysglycaemiaA person is clinically stable and a screening or symptom-driven test is above the diagnostic threshold.+
  1. 1Verify that the method and sampling conditions are valid, specifically checking symptoms and factors that make HbA1c unsuitable.
  2. 2AlternativeIf classic symptoms are absent, confirm on another day with the same or an alternative accepted laboratory test; investigate major discordance rather than averaging values.
  3. 3Communicate the diagnosis, likely type and immediate plan, assess cardiovascular and renal risk, and arrange structured education and follow-up ownership.
03PreventManage non-diabetic hyperglycaemiaHbA1c or fasting glucose lies in the recognised high-risk range without meeting diabetes criteria.+
  1. 1Explain absolute risk in a non-stigmatising way and identify modifiable weight, activity, dietary, smoking and cardiovascular factors.
  2. 2Offer referral to an intensive evidence-based diabetes prevention programme when eligible, adapting access for disability, culture and socioeconomic barriers.
  3. 3EscalationRepeat glycaemic assessment at least annually, earlier if symptoms or steroid exposure arise, and escalate if a diagnostic threshold is reached.

Risks, monitoring and follow-up

  • Document the diagnostic test, units, symptom status, validity checks and any confirmatory result so that the basis for diagnosis remains auditable.
  • For non-diabetic hyperglycaemia, repeat HbA1c or fasting glucose at least annually and add symptom-triggered testing rather than waiting for the next cycle.
  • After diagnosis, establish baseline blood pressure, lipids, renal function, urine albumin-creatinine ratio, weight and smoking status to direct risk reduction.
  • Revisit diabetes classification when insulin requirements, ketones, C-peptide, autoantibodies or family phenotype do not behave as originally expected.
  • Ensure pregnancy intention and current pregnancy are asked about because diagnostic interpretation and glucose targets require a different specialist pathway.

Special situations

Symptoms change confirmation

A diagnostic venous glucose plus classic osmotic symptoms establishes diabetes, whereas the same result found on asymptomatic screening usually needs repetition to exclude chance or transient elevation.

HbA1c is biological history

It reflects glycation over the lifespan of circulating red cells, not today's glucose. Rapid autoimmune decline can therefore become dangerous before HbA1c crosses the threshold.

Discordance deserves explanation

Do not choose whichever of glucose and HbA1c best fits an assumption. Consider recent onset, haemolysis, iron deficiency, haemoglobin variant, kidney disease and analytical method.

Type follows mechanism

Age and adiposity influence probability but do not define diabetes type. Autoimmunity, endogenous insulin reserve, pancreatic history and inherited phenotypes can overturn first impressions.

High risk is actionable

Non-diabetic hyperglycaemia is not a harmless near miss. Prevention services and cardiovascular risk management can reduce downstream disease while avoiding an incorrect diabetes label.

Common pitfalls

  1. 01

    Using HbA1c to rule out type 1 diabetes in a patient whose osmotic symptoms began two weeks ago.

  2. 02

    Diagnosing an asymptomatic person from one borderline result without confirming that the test was valid and reproducible.

  3. 03

    Applying adult non-pregnant HbA1c thresholds to suspected gestational diabetes.

  4. 04

    Calling HbA1c 42–47 mmol/mol diabetes rather than non-diabetic hyperglycaemia requiring prevention and surveillance.

  5. 05

    Assuming an older or overweight patient cannot have autoimmune diabetes despite ketosis and catabolic symptoms.

  6. 06

    Leaving classification and complication assessment for a distant review after communicating a new diagnosis.